RBFOX2 and diabetes mellitus: De novo mutations in Rbfox2 have also been identified in congenital heart disease (Homsy et al., 2015), and alterations in Rbfox2 activity may be an early event in diabetes-induced heart pathology (Nutter et al., 2016).